Kodiak Sciences: Daybreak Needs To Deliver More Than A Passing Grade
Kodiak Sciences expects Phase 3 DAYBREAK results for Zenkuda and KSI-501 in wet AMD, with durability and vision outcomes key beyond…
Sam Mancini NASDAQ
Kodiak Sciences Inc.
KOD
1 article
$2.1B Market cap · 2026-09-14
Sam Mancini 